Healthy Q3, despite various headwinds
05/08/22 -"Despite Chinese lockdowns and supply-chain limitations, CZM managed to report healthy Q3 21/22 results. Both segments reported healthy growth, whereas the order intake was all the more impressive. ..."
Pages
63
Language
English
Published on
05/08/22
You may also be interested by these reports :
03/08/26
Our TP has been cut slightly, reflecting an update to the model (net debt, and updated market parameters), with no change to the operational ...
03/08/26
Smart glasses development continues to erode margins. We will take a more conservative view of the company and revise our long-term margin ...
02/08/26
DiaSorin’s Q2 profitability surpassed expectations. Despite weak respiratory sales and challenges in China, revenue grew by mid-single digits. All ...
31/07/26
Siemens Healthineers’ Q3 sales slightly missed expectations, though profitability met forecasts. The Precision Therapy and Imaging segments reported ...